Home / Conditions / Type 2 Diabetes

Type 2 Diabetes

Type 2 Diabetes Research and News: Type 2 diabetes is a metabolic disorder. Though most commonly diagnosed in the elderly, younger adults and even children are increasingly subject to the disease. 9.4% of the US population has Type 2 diabetes or about 30 million Americans. Approximately 95% of all adults diagnosed with diabetes have Type 2. New tools, techniques and treatments can help you improve outcomes for your Type 2 diabetes patients.

Can Resistant Starch Lower Your Next Blood Sugar Spike? Inside the “Second-Meal Effect”

Resistant starch foods including oats, legumes, bananas, and whole grains illustrating the second-meal effect on blood sugar.

Could the carbohydrates eaten at breakfast affect the blood sugar response to lunch? Research on resistant starch and the second-meal effect suggests they might. Resistant starch escapes much of the digestion that normally occurs in the small intestine. As a result, less of it is immediately converted to glucose, while …

Read More »

Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?

Blood sample illustrating epigenetic cardiovascular risk prediction using DNA methylation to assess heart risk in type 2 diabetes.

Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …

Read More »

GLP-1s and Opioids: The GI Risk Clinicians May Be Missing

GLP-1 medications and opioid therapy representing potential gastrointestinal risks from concurrent treatment.

GLP-1 receptor agonists have transformed the treatment of type 2 diabetes, but their effects on gastrointestinal motility remain an important clinical consideration. Opioids can also slow gastrointestinal function, raising an obvious question: what happens when patients need both? New research examining GLP-1 and opioid interactions suggests that opioid choice may …

Read More »

Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?

Patient with Type 2 diabetes using real-time CGM while receiving maintenance hemodialysis.

Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …

Read More »

A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?

Clinician reviewing A1C and glycated albumin results for type 2 diabetes monitoring

A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …

Read More »

Digital Diabetes Coaching: Why an App Alone Isn’t Enough

Person with type 2 diabetes using a digital health app while receiving virtual diabetes coaching and tracking healthy lifestyle goals.

A diabetes app can track meals, count steps, log glucose, and deliver reminders. However, can an app actually help someone turn all that information into lasting daily habits? A recent randomized controlled trial suggests that digital diabetes coaching, with technology supported by ongoing human guidance, may help bridge that gap. …

Read More »

More Dietary Fat, Worse Blood Fats? A Low-Carb Diabetes Trial Challenges the Assumption

Low-carb foods including salmon, avocado, nuts, vegetables, and olive oil beside a glucose meter and heart health chart.

Does eating more fat automatically mean that more harmful fatty acids will circulate in the blood? A new randomized trial suggests the answer may be more complicated. Researchers studying a low-carb diet for type 2 diabetes found that six months of carbohydrate restriction changed circulating fatty acids in potentially favorable …

Read More »